Your Client Rank:
Loading...
99
Updated 21-Dec-2024
Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
Lilly | 22.7% | 0.7% | -8.1% | -13.2% | 18.5% | -5.2% | 46.7% | 47.0% |
Novo | 16.8% | 0.0% | -3.1% | 0.7% | 1.3% | 0.4% | 17.7% | 18.9% |
Daiichi | 12.1% | 2.3% | 2.3% | -3.4% | 11.2% | 6.2% | 20.2% | 21.2% |
Vertex | 9.7% | 0.5% | 1.9% | -6.5% | 2.4% | 1.2% | 12.1% | 11.4% |
Astra | 8.4% | 0.0% | -3.3% | -0.3% | 4.6% | 3.3% | 11.6% | 11.3% |
Regeneron | 7.3% | 0.2% | -0.8% | 0.2% | 2.5% | 14.2% | 9.0% | 9.1% |
AbbVie | 6.0% | 0.2% | -3.0% | -2.2% | 2.1% | 1.5% | 8.6% | 8.7% |
Eisai | 5.9% | -0.5% | -0.1% | -4.0% | 8.6% | -3.8% | 14.3% | 15.2% |
Merck | 5.5% | 1.2% | -2.9% | -16.7% | 34.7% | -15.7% | 51.9% | 52.6% |
Amgen | 5.2% | -0.3% | 0.1% | 1.6% | -0.6% | -1.1% | 4.4% | 4.7% |
Lundbeck | 4.2% | 1.3% | -2.5% | 3.6% | 4.2% | 2.3% | 11.2% | 5.4% |
JnJ | 3.9% | -0.1% | -0.7% | -0.7% | 0.9% | 2.8% | 3.5% | 4.9% |
Sanofi | 3.9% | 1.0% | -4.2% | 0.3% | 6.1% | 1.2% | 5.4% | 6.9% |
Novartis | 3.8% | 0.0% | -2.7% | 0.0% | 3.6% | 1.7% | 6.0% | 7.2% |
Roche | 3.7% | 0.3% | -1.4% | -1.7% | 2.6% | 9.3% | 5.5% | 5.1% |
Chugai | 3.6% | 3.1% | 0.8% | -0.1% | 4.0% | 0.5% | 7.4% | 7.4% |
Teva | 3.4% | 1.1% | | | 2.0% | 4.2% | 7.3% | 6.6% |
Glaxo | 3.0% | 0.2% | -1.1% | -0.1% | 3.1% | 2.4% | 5.4% | 4.5% |
Gilead | 2.7% | -0.1% | -2.1% | -3.9% | 3.4% | 6.3% | 4.9% | 5.3% |
Takeda | 2.1% | 0.5% | -0.7% | -0.3% | 23.3% | | 3.8% | 3.5% |
Shionogi | 1.9% | -0.3% | -2.5% | -0.8% | -0.3% | 1.7% | 0.4% | 2.7% |
Astellas | 1.4% | -0.7% | -6.0% | 1.0% | 14.7% | 1.7% | 16.0% | 15.5% |
Pfizer | 1.0% | 4.8% | -2.0% | 0.0% | 15.7% | 11.2% | 10.3% | 9.2% |
Bayer | 0.1% | -0.3% | -0.3% | 3.0% | -1.0% | | -3.4% | -3.0% |
Biogen | 0.0% | 1.4% | -0.4% | -2.4% | 5.5% | 1.4% | 5.9% | 6.1% |
Bristol | -1.6% | -0.3% | 1.4% | -0.2% | -0.8% | 3.1% | -5.2% | -4.1% |
Neurocrine | | | | | | | | |
EU Major | 5.5% | 0.6% | -2.3% | -0.1% | 4.0% | 1.1% | 8.1% | 6.6% |
Other EU | 4.2% | 1.3% | -2.5% | 3.6% | 4.2% | 2.3% | 11.2% | 5.4% |
US Major | 6.0% | 1.2% | -2.8% | -7.0% | 8.9% | 0.1% | 14.5% | 19.8% |
US Big Biotech | 4.8% | 0.2% | -1.2% | -1.8% | 2.1% | 2.9% | 6.6% | 8.0% |
Other US | 3.4% | 1.1% | | | 2.0% | 4.2% | 7.3% | 6.6% |
Japanese | 4.3% | 0.9% | -0.5% | -0.9% | 10.9% | 11.0% | 8.3% | 8.6% |